Login
$JANX
$11.12 +$0.20 (1.83%) After hours

Company Executives

Officer Age In this role 2025 pay Source
David Campbell Also a director
President and Chief Executive Officer
67 Not stated $13,506,231
Thomas DiRaimondo
Chief Scientific Officer
40 Since 2024
2 years
$4,345,469
William Go
Chief Medical Officer
50 Since 2026
this year
Not reported
Charles Winter
Chief Technical Officer
57 Since 2023
3 years
Not reported
Maria Dobek
Vice President, Accounting
Title from the Form 4 dated May 11, 2026
Not stated Not stated Not reported
Janeen Doyle
Chief Corp. & Bus. Dev. Ofcr
Title from the Form 4 dated Jun 2, 2026
48 Not stated $4,669,292

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
4.7 years
from year joined
CEO also chairs the board
No
Ron Barrett, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Ron Barrett, Ph.D.
70 2021
5 years
Independent None stated None stated $420,779
David Campbell, Ph.D.
67 2017
9 years
Not independent None stated None stated Paid as CEO
Natasha Hernday
54 2024
2 years
Independent None stated Xoma Corp. $374,216
Eric Dobmeier
57 2024
2 years
Independent None stated Structure Therapeutics, Inc. $376,091
Vickie Capps
64 2021
5 years
Independent None stated Orthofix Medical, Inc. $389,216
Jake Simson, Ph.D.
40 2021
5 years
Independent None stated Tyra Biosciences, Inc., Bicara Therapeutics, Inc., Septerna Inc. $381,591
Winston Kung
50 2022
4 years
Independent
Audit
Corbus Pharmaceuticals $379,841
Sheila Gujrathi, M.D. Leaving at the meeting
55 2021
5 years
Independent None stated Ventyx Biosciences, Inc. $370,466
Alana McNulty Leaving at the meeting
63 2021
5 years
Independent
Audit
None stated $379,841

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support